Rapamycin News

Rapamycin News

Publication
0 followers

Community-driven news and discussion focused on rapamycin and related longevity interventions.

Lipoprotein (Lipid) - A Deep Dive Into Genetic Pathways for Actionable Insights
NewsApr 15, 2026

Lipoprotein (Lipid) - A Deep Dive Into Genetic Pathways for Actionable Insights

A comprehensive genetic analysis of lipoprotein pathways reveals a PCSK9 gain‑of‑function homozygous variant, a MYLIP loss‑of‑function hit, and a protective NPC1L1 loss‑of‑function allele. The profile also shows an APOA5 risk genotype that is currently offset by high‑dose omega‑3, tirzepatide and...

By Rapamycin News
GHK-Cu Peptide Rescues Aging Cognition but Splits Molecular Pathways in the Brain
NewsApr 15, 2026

GHK-Cu Peptide Rescues Aging Cognition but Splits Molecular Pathways in the Brain

Researchers examined the copper‑binding peptide GHK‑Cu, noting its molecular weight of about 402 g/mol and a 15.8% copper composition. Translating the mouse dose of 15 mg/kg to humans yields an 85 mg daily intake, delivering roughly 13.4 mg elemental copper—well above the 10 mg tolerable...

By Rapamycin News
Hair Loss and Graying - A Deep Dive Into Genetic Pathways for Actionable Insights
NewsApr 15, 2026

Hair Loss and Graying - A Deep Dive Into Genetic Pathways for Actionable Insights

A detailed personal genomics report links specific DNA variants to hair loss and premature graying, highlighting a homozygous NRF2 impairment, a four‑gene glutathione bottleneck, and a quadruple SRD5A1/2 genotype that perfectly matches dutasteride therapy. The analysis recommends high‑priority sulforaphane supplementation,...

By Rapamycin News
Loyal Raises $100 Million: Dog Longevity Drugs Targeting IGF-1 and PPAR Pathways
NewsApr 13, 2026

Loyal Raises $100 Million: Dog Longevity Drugs Targeting IGF-1 and PPAR Pathways

Loyal, a veterinary biotech firm, announced a $100 million financing round to advance its canine longevity platform. The company targets the IGF‑1 and PPAR pathways to develop drugs that extend the lifespan of senior and large‑breed dogs. It has secured conditional...

By Rapamycin News
Magnetic Fields From Earphones and Mobile Phones 'Suck' Airborne Magnetic Particles Into the Brain, Impairing Cognition and Potentially Contributing to...
NewsApr 13, 2026

Magnetic Fields From Earphones and Mobile Phones 'Suck' Airborne Magnetic Particles Into the Brain, Impairing Cognition and Potentially Contributing to...

A Chinese Academy of Sciences team published in ACS Nano that static magnetic fields from everyday earphones and smartphones dramatically increase brain accumulation of airborne magnetite nanoparticles in mice. The combined exposure amplified nanoparticle uptake by roughly five times and caused...

By Rapamycin News
Magnetic Fields From Earphones and Mobile Phones 'Suck' Airborne Magnetic Particles Into the Brain, Impairing Cognition and Potentially Contributing to...
NewsApr 13, 2026

Magnetic Fields From Earphones and Mobile Phones 'Suck' Airborne Magnetic Particles Into the Brain, Impairing Cognition and Potentially Contributing to...

The article argues that coal‑fired power plants emit far more radioactive material than nuclear facilities because fly ash concentrates uranium and thorium up to tenfold, delivering radiation roughly 100 times higher than an equivalent nuclear plant. Multiple peer‑reviewed studies show...

By Rapamycin News
New Toothpaste Stops Gum Disease without Killing Good Bacteria
NewsApr 13, 2026

New Toothpaste Stops Gum Disease without Killing Good Bacteria

Scientists have created a toothpaste that combats gum disease by selectively blocking harmful microbes while leaving beneficial oral bacteria untouched. The formulation uses a targeted antimicrobial peptide that interferes with pathogenic biofilm formation, a departure from conventional broad‑spectrum agents that...

By Rapamycin News
Easy Hacks Guide Targeting Different Biomarkers (BMI, apoB, Blood Pressure, HbA1c, eGFR, Etc)
NewsApr 13, 2026

Easy Hacks Guide Targeting Different Biomarkers (BMI, apoB, Blood Pressure, HbA1c, eGFR, Etc)

A user reports losing about 5 lb since July while taking empagliflozin 12.5 mg daily, noting increased thirst and a modest calorie loss from urinary glucose excretion. They stopped a supplement called Glylo after experiencing tingling, which coincided with a rise in...

By Rapamycin News
Sarcopenia -- New Clues
NewsApr 13, 2026

Sarcopenia -- New Clues

Recent preclinical and clinical work links low‑grade inflammation to age‑related muscle loss, or sarcopenia, and shows that ibuprofen can blunt this process. In 20‑month‑old rats, a five‑month ibuprofen regimen cut inflammatory markers by up to 60% and boosted post‑prandial muscle...

By Rapamycin News
The Cellular Incinerator: How Interventions Like Rapamycin Hijack Autophagy to Hack Aging
NewsApr 13, 2026

The Cellular Incinerator: How Interventions Like Rapamycin Hijack Autophagy to Hack Aging

A recent review by Ebata and Hansen (2026) synthesizes evidence that dietary restriction, intermittent fasting, spermidine‑rich foods, exercise, sleep hygiene, and hormetic temperature stress all stimulate autophagy—a cellular recycling process linked to longer healthspan. In model organisms, these interventions require...

By Rapamycin News
The Geriatric Protein Paradox: Malnutrition Scales Linearly Into the Extreme Limits of Human Lifespan
NewsApr 12, 2026

The Geriatric Protein Paradox: Malnutrition Scales Linearly Into the Extreme Limits of Human Lifespan

A large survey of 1,497 Chinese adults aged 80 to over 110 found a linear increase in clinical malnutrition as age advances, with the steepest deficits observed in centenarians. Using the Geriatric Nutritional Risk Index, researchers showed each additional year...

By Rapamycin News
Gut Microbes and Plant Extracts: A Synergistic Formula for Reclaiming Muscle Power?
NewsApr 12, 2026

Gut Microbes and Plant Extracts: A Synergistic Formula for Reclaiming Muscle Power?

The article reviews a supplement protocol that pairs polyphenol‑rich plant extracts—curcumin, pomegranate, green tea, broccoli, cranberry and ginger—with a five‑strain Lactobacillus probiotic, inulin and vitamin D, taken as two capsules daily. Pharmacokinetic data show that unformulated curcumin and EGCG have very...

By Rapamycin News
Diet and Death in the Chinese Elderly: Plant-Based and Meat-Heavy Patterns Show Divergent Sex-Specific Mortality Risks
NewsApr 12, 2026

Diet and Death in the Chinese Elderly: Plant-Based and Meat-Heavy Patterns Show Divergent Sex-Specific Mortality Risks

A new epidemiological study of Chinese adults with a mean age over 85 reveals stark sex‑specific mortality patterns linked to diet. Elderly men who consume a meat‑heavy, animal‑protein‑rich “Carnivorous” pattern experience significantly lower death rates, while women on a sugar‑laden...

By Rapamycin News
Lessons From My (Nearly) Centenarian Mother
NewsApr 12, 2026

Lessons From My (Nearly) Centenarian Mother

The article examines why certain personality disorders, especially those in DSM‑5’s Cluster B, are notoriously hard to treat. Antisocial Personality Disorder and psychopathy emerge as the most resistant, with limited evidence of therapeutic benefit. Borderline Personality Disorder shows promising long‑term remission...

By Rapamycin News
Lest We "Off" Ourselves (Cautionary Examples)
NewsApr 12, 2026

Lest We "Off" Ourselves (Cautionary Examples)

Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson were hospitalized with severe sepsis after receiving experimental stem‑cell and related regenerative therapies from Dr. Adil Khan’s unregulated clinics in Mexico and other offshore locations. Hyman’s spinal injections for...

By Rapamycin News
The Fiber Fix: Isolated Soluble Fiber Drives Clinically Meaningful Weight Loss and Metabolic Repair
NewsApr 12, 2026

The Fiber Fix: Isolated Soluble Fiber Drives Clinically Meaningful Weight Loss and Metabolic Repair

Vitafusion Fiber Well markets a gummy that delivers 5 g of polydextrose (PDX) per serving, positioning it as a soluble fiber for weight loss and metabolic repair. Scientific review shows PDX ferments slowly throughout the colon, generating short‑chain fatty acids that...

By Rapamycin News
GLP-1 Micro Dosing - Strategies and Tactics?
NewsApr 11, 2026

GLP-1 Micro Dosing - Strategies and Tactics?

A Reddit user is experimenting with micro‑dosing GLP‑1 agonists, currently injecting 3 mg tirzepide weekly and planning to use a 7 mg generic oral semaglutide tablet. The goal is to reduce visceral adipose tissue and support cartilage regeneration after knee injections, targeting...

By Rapamycin News
Elastin Fragments Identified as Drivers of Systemic Aging
NewsApr 11, 2026

Elastin Fragments Identified as Drivers of Systemic Aging

Recent research identifies macrophage elastase (MMP‑12) as a key enzyme that creates toxic elastin fragments, driving systemic aging. Low‑dose doxycycline, a known matrix metalloproteinase inhibitor, can prevent elastin degradation and has been used off‑label for periodontal disease and aneurysm management....

By Rapamycin News
Resistance Training: The Muscle Miracle: Can I Build Enough in My 60s to Make It to 100 – Even Though...
NewsApr 11, 2026

Resistance Training: The Muscle Miracle: Can I Build Enough in My 60s to Make It to 100 – Even Though...

A growing body of research shows that seniors can substantially preserve or even increase muscle mass through targeted resistance training combined with adequate leucine‑rich protein intake. Guidelines recommend 3‑4 g of leucine (about 30 g of protein) per main meal for people...

By Rapamycin News
Imeglimin. A New and Novel Drug Thats Better than Metformin
NewsApr 10, 2026

Imeglimin. A New and Novel Drug Thats Better than Metformin

Imeglimin, a novel oral antidiabetic approved in Japan and the EU, improves mitochondrial bioenergetics and reduces HbA1c more effectively than metformin. Its renal excretion bypasses the CYP3A4 pathway, eliminating pharmacokinetic conflicts with rapamycin, an mTOR inhibitor used in longevity protocols....

By Rapamycin News
Amount of Central Fat Predicts Mortality Risk in Non-Obese Individuals
NewsApr 10, 2026

Amount of Central Fat Predicts Mortality Risk in Non-Obese Individuals

The transcript presents evidence‑based dietary protocols that can dramatically lower visceral and hepatic fat without major weight loss. Clinical trials such as DIRECT‑PLUS, DiRECT and RS2 studies demonstrate that polyphenol‑rich foods, higher protein intake, unsaturated fats and resistant starch can...

By Rapamycin News
RW-ApoB -- Superior Metric For Lipid Related CVD Risk --- Using Lp(a), ApoB, and Triglycerides
NewsApr 10, 2026

RW-ApoB -- Superior Metric For Lipid Related CVD Risk --- Using Lp(a), ApoB, and Triglycerides

Researchers introduced risk‑weighted apoB (RW‑ApoB), a composite metric that integrates LDL‑C, triglyceride‑rich remnants, and lipoprotein (a) to better predict coronary heart disease. Using data from 285,060 UK Biobank participants not on lipid‑lowering therapy, RW‑ApoB demonstrated higher CHD prediction accuracy than traditional...

By Rapamycin News
Imeglimin. A New and Novel Drug Thats Better than Metformin
NewsApr 10, 2026

Imeglimin. A New and Novel Drug Thats Better than Metformin

A forum post discusses the practical use of GH secretagogues, GLP‑1 agonists such as tirzepatide and semaglutide, and the experimental drug imeglimin, arguing that careful titration and hormone optimization are essential for efficacy. The author, a 72‑year‑old male, reports IGF‑1...

By Rapamycin News
Rhamnan Sulfate an Agent that Might Protect Microcirculation, Vascular Endothelium and Glycocalyx
NewsApr 9, 2026

Rhamnan Sulfate an Agent that Might Protect Microcirculation, Vascular Endothelium and Glycocalyx

Rhamnan sulfate (RS), extracted from the Japanese seaweed Monostroma nitidum, is emerging as a supplement that targets the endothelial glycocalyx rather than nitric‑oxide pathways. Early cell studies show RS restores glycocalyx thickness and cuts LDL permeability threefold, while ApoE‑deficient mice...

By Rapamycin News
Urolithin A (UA) One of 4 Promising Agents 2024 by Brian Kennedy of NSU
NewsApr 9, 2026

Urolithin A (UA) One of 4 Promising Agents 2024 by Brian Kennedy of NSU

Urolithin A (UA) is highlighted as one of four promising anti‑aging agents for 2024, backed by both human and animal research. A double‑blind, placebo‑controlled trial in 50 middle‑aged adults showed that 1,000 mg daily UA enhanced immune cell phenotypes, mitochondrial biogenesis, and...

By Rapamycin News
Don’t Waste Your Money on Expensive EVOO or ‘High Polyphenol’ Olive Oil!
NewsApr 9, 2026

Don’t Waste Your Money on Expensive EVOO or ‘High Polyphenol’ Olive Oil!

A review of clinical and mechanistic data finds extra‑virgin olive oil (EVOO), especially high‑polyphenol varieties, superior to canola oil for cardiovascular health. The PREDIMED trial (≈7,400 high‑risk participants) reported a 31% reduction in major events with about four tablespoons of...

By Rapamycin News
2g/Day of DHA for 2 Years Has No Impact on Cognition or Hippocampal Volume
NewsApr 9, 2026

2g/Day of DHA for 2 Years Has No Impact on Cognition or Hippocampal Volume

A two‑year randomized trial gave participants 2 g of DHA daily and found no measurable improvement in cognitive performance or hippocampal volume. The null result adds to a growing body of RCTs that fail to demonstrate brain benefits from DHA supplementation...

By Rapamycin News
Cell-to-Cell Power Grid: How Mitochondrial Transplantation Is Redefining Metabolic Aging and Tissue Rescue
NewsApr 9, 2026

Cell-to-Cell Power Grid: How Mitochondrial Transplantation Is Redefining Metabolic Aging and Tissue Rescue

A new comprehensive literature review evaluates mitochondrial transplantation (MTx) and the Drp1 inhibitor Mdivi‑1 as experimental strategies to reverse metabolic aging in diabetic animal models. The analysis highlights how MSC‑derived mitochondria can induce mitophagy, suppress apoptosis, and modulate immune pathways...

By Rapamycin News
Obesity Pills: Orforglipron Outpaces Semaglutide: Next-Gen Oral GLP-1 Agonist Drives Superior Glycemic and Weight Control
NewsApr 8, 2026

Obesity Pills: Orforglipron Outpaces Semaglutide: Next-Gen Oral GLP-1 Agonist Drives Superior Glycemic and Weight Control

The phase 3 ACHIEVE‑3 trial showed that oral orforglipron outperformed oral semaglutide in both glycemic control and weight loss for type 2 diabetes patients. At 52 weeks, the 36 mg dose reduced HbA1c by 1.91% versus 1.47% for semaglutide and achieved an 8.2% weight...

By Rapamycin News
Top 5 - Which Currently Available Longevity Interventions Do You Think Are the Best
NewsApr 8, 2026

Top 5 - Which Currently Available Longevity Interventions Do You Think Are the Best

A community thread explores a range of longevity interventions, from metabolic drugs like pioglitazone and Imeglimin to neuro‑activators such as modafinil and orexin‑targeting strategies. Participants share personal dosing experiences, highlight safety concerns—including heart‑failure and bladder‑cancer risks for pioglitazone and dangerous...

By Rapamycin News
New Study Says I Was Wrong About NMN and NR?
NewsApr 7, 2026

New Study Says I Was Wrong About NMN and NR?

A recent Norwegian crossover study reported that nicotinamide riboside (NR) raised blood NAD levels 2.3‑fold higher than nicotinamide mononucleotide (NMN) in six healthy adults. However, a larger 65‑participant Nature Metabolism trial found both NR and NMN roughly doubled NAD after...

By Rapamycin News
University of Arizona Launches $12 Million Rapamycin Clinical Trial
NewsApr 7, 2026

University of Arizona Launches $12 Million Rapamycin Clinical Trial

The University of Arizona’s R. Ken Coit College of Pharmacy is launching a double‑blind, randomized Phase 3 clinical trial to test low‑dose rapamycin’s ability to boost resilience and immune function in adults aged 65 and older. The six‑year study, funded by a...

By Rapamycin News
Atherosclerosis - A Very Deep Dive Into Endothelial Health Genetic Pathways for Actionable Insights
NewsApr 7, 2026

Atherosclerosis - A Very Deep Dive Into Endothelial Health Genetic Pathways for Actionable Insights

The article presents a detailed three‑phase workflow for analyzing endothelial‑health genetic pathways, starting with evidence‑based SNP research, then producing a generic reference DOCX, and finally delivering a personalized report that maps genotype results to supplement and medication guidance. It mandates...

By Rapamycin News
Coenzyme Q10 (CoQ10) U-Shaped Dose-Response Relation with Blood Glucose and Blood Pressure
NewsApr 7, 2026

Coenzyme Q10 (CoQ10) U-Shaped Dose-Response Relation with Blood Glucose and Blood Pressure

A short‑term ubiquinol regimen of 200 mg per day for two weeks boosted strength and endurance while lowering perceived exertion in moderately trained adults. Muscle‑damage biomarkers also fell, indicating protective effects after strenuous exercise. Separate meta‑analyses suggest CoQ10 supplementation can cut...

By Rapamycin News
Atherosclerosis - A Very Deep Dive Into Endothelial Health Genetic Pathways for Actionable Insights
NewsApr 7, 2026

Atherosclerosis - A Very Deep Dive Into Endothelial Health Genetic Pathways for Actionable Insights

A recent deep‑dive genetic report examined 20 SNPs across nine pathways linked to endothelial function and coronary artery disease. The analysis identified homozygous risk variants in GUCY1A3, PCSK9, PDE5A, ICAM1, XDH and SPR that collectively blunt NO‑cGMP signaling and raise...

By Rapamycin News
Atherosclerosis - A Very Deep Dive Into Endothelial Health Genetic Pathways for Actionable Insights
NewsApr 7, 2026

Atherosclerosis - A Very Deep Dive Into Endothelial Health Genetic Pathways for Actionable Insights

A personal genome analysis of 20 SNPs across nine functional categories identified critical vulnerabilities in nitric‑oxide signaling, highlighted by a double‑hit in GUCY1A3 and a PCSK9 gain‑of‑function variant that elevates LDL‑C. Additional risk alleles include a heterozygous 9p21 CAD locus,...

By Rapamycin News
Lest We "Off" Ourselves (Cautionary Examples)
NewsApr 7, 2026

Lest We "Off" Ourselves (Cautionary Examples)

Investigative videos released by Mark Hyman and Jordan Peterson expose severe sepsis cases linked to experimental stem‑cell injections administered by Dr. Adil Khan’s unregulated regenerative‑medicine clinics. Hyman’s spinal injections for disc degeneration allegedly introduced a bacterial infection, while Peterson’s extensive...

By Rapamycin News
Lest We "Off" Ourselves (Cautionary Examples)
NewsApr 7, 2026

Lest We "Off" Ourselves (Cautionary Examples)

Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after receiving experimental stem‑cell and related injections from Dr. Adil Khan’s unregulated clinics. The series links spinal and intravenous therapies to bacterial infections, highlighting the doctors’...

By Rapamycin News
Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate
NewsApr 7, 2026

Retatrutide - Possibly Better than Semaglutide B/C Lower Nausea/Side Effect Profile, but Higher Heart Rate

Retatrutide, a next‑generation GLP‑1/GIP/Glucagon agonist, appears to cause less nausea than semaglutide while delivering comparable weight‑loss efficacy, but early data show a modest increase in resting heart rate. Patient anecdotes highlight typical GLP‑1 side effects—transient nausea, bowel habit shifts, occasional...

By Rapamycin News
Lest We "Off" Ourselves (Cautionary Examples)
NewsApr 7, 2026

Lest We "Off" Ourselves (Cautionary Examples)

Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after receiving experimental stem‑cell and related injections from Dr. Adil Khan’s unregulated clinics. The series links Hyman’s spinal abscess and Peterson’s pneumonia‑sepsis to a pattern of...

By Rapamycin News
[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data
NewsApr 7, 2026

[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data

Project Glasswing warns that soon‑to‑be‑released AI agents are vulnerable to hidden prompt injections and memory‑poisoning attacks, with success rates as high as 86% and 80% respectively. DeepMind has identified six attack layers—from perception to human supervision—demonstrating proof‑of‑concept exploits that could...

By Rapamycin News
Rowansci for Computational Chemistry of Your Favorite Molecules. Free Credits
NewsApr 7, 2026

Rowansci for Computational Chemistry of Your Favorite Molecules. Free Credits

Rowan offers a cloud‑based quantum‑chemistry platform with free compute credits, enabling users to run GFN2‑xTB and other methods on complex molecules. In a rapamycin case study, the tool identified electrophilic hotspots concentrated in oxygen‑rich carbonyl/ester regions and mapped electron‑rich sites...

By Rapamycin News
Rowansci for Computational Chemistry of Your Favorite Molecules. Free Credits
NewsApr 7, 2026

Rowansci for Computational Chemistry of Your Favorite Molecules. Free Credits

RowanSci’s recent run on rapamycin identified a suite of low‑frequency vibrational modes between 3 and 32 cm⁻¹, with a single small imaginary mode treated as a floppy coordinate. The analysis mapped these soft motions to the same atoms that exhibit the...

By Rapamycin News
[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data
NewsApr 7, 2026

[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data

Project Glasswing warns that emerging AI models could become vectors for massive cyber‑attacks, citing an 86% success rate for hidden prompt‑injection attacks and a 0.1% poisoned‑data threshold that corrupts agents with over 80% certainty. DeepMind identifies six attack layers—perception, reasoning,...

By Rapamycin News
[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data
NewsApr 7, 2026

[Cybersecurity Thread] ""Soon-to-Be-Released AI Models Could Enable a World-Shaking Cyberattack This Year", Protect Your Healthcare Data

Project Glasswing warns that emerging AI agents are vulnerable to hidden prompt injections and memory‑poisoning attacks, with success rates of 86% and over 80% respectively. The research, cited by DeepMind, shows attackers can embed malicious instructions in HTML or contaminated...

By Rapamycin News
Growth Hormone Supplementation Can Restore the Thymus, but What Is Its Effect on Lifespan?
NewsApr 7, 2026

Growth Hormone Supplementation Can Restore the Thymus, but What Is Its Effect on Lifespan?

Recent debates on growth hormone (GH) supplementation highlight its ability to rejuvenate the thymus but raise serious concerns about lifespan effects. Experts from the 2013 Erice workshop and subsequent literature argue that while transient GH can restore immune tissue, chronic...

By Rapamycin News
Lest We "Off" Ourselves (Cautionary Examples)
NewsApr 7, 2026

Lest We "Off" Ourselves (Cautionary Examples)

Investigative videos reveal that wellness influencers Mark Hyman and Jordan Peterson suffered severe sepsis after receiving experimental stem‑cell and regenerative‑medicine injections from Dr. Adil Khan’s unregulated clinics. The series links spinal injections and intravenous therapies to life‑threatening infections, highlighting the...

By Rapamycin News
Parkinson's Disease
NewsApr 7, 2026

Parkinson's Disease

Recent preclinical and early clinical studies explore a range of nutraceuticals and repurposed drugs that target oxidative stress, metal homeostasis, and gut integrity in Parkinson’s disease. Benfotiamine combined with methylcobalamin showed symptomatic improvement in a case series and activates Nrf2...

By Rapamycin News
Vitamin C Re-Evaluated: A Direct Inhibitor of the 'Ferro-Aging' Clock
NewsApr 7, 2026

Vitamin C Re-Evaluated: A Direct Inhibitor of the 'Ferro-Aging' Clock

A 2026 Cell Metabolism study gave aged cynomolgus monkeys 30 mg kg⁻¹ vitamin C daily via drinking water for 40 months, showing direct inhibition of the ACSL4‑driven ferro‑aging clock. Pharmacokinetic data reveal vitamin C’s plasma half‑life ranges from 30 minutes to two hours at high doses,...

By Rapamycin News